Literature DB >> 657992

Antiplatelet agents in coronary disease: are they of prophylactic value?

M Verstraete.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 657992     DOI： 10.2165/00003495-197815060-00004

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  29 in total

1.  Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts.

Authors:  P Steele; D Battock; G Pappas; E Genton
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

2.  A controlled clinical trial of 'persantin' (R A 8) in angina pectoris.

Authors:  M M ZION; B A BRADLOW
Journal:  S Afr Med J       Date:  1961-01-07

3.  A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.

Authors:  J A Heady
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  Letter: Difficulties of classification and terminology of syndromes of multiple congenital anomalies.

Authors:  J Warkany
Journal:  Am J Dis Child       Date:  1974-09

5.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement.

Authors:  J M Sullivan; D E Harken; R Gorlin
Journal:  N Engl J Med       Date:  1971-06-24       Impact factor: 91.245

6.  Use of Persantine in preventing thromboembolism following valve replacement.

Authors:  J E Arrants; P Hairston
Journal:  Am Surg       Date:  1972-08       Impact factor: 0.688

7.  Cerebral embolization: prospective clinical analysis of 42 cases.

Authors:  J S Meyer; J Z Charney; V M Rivera; N T Mathew
Journal:  Stroke       Date:  1971 Nov-Dec       Impact factor: 7.914

8.  Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.

Authors:  S Sbar; R C Schlant
Journal:  JAMA       Date:  1967-09-11       Impact factor: 56.272

9.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.

Authors:  J M Sullivan; D E Harken; R Gorlin
Journal:  N Engl J Med       Date:  1968-09-12       Impact factor: 91.245

10.  Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.

Authors: 
Journal:  Br Med J       Date:  1971-12-25
View more
  4 in total

Review 1.  Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  The effect of antiaggregating drugs on the patency of grafts in the arterial system.

Authors:  J Pirk; V Ruzbarský; J König; M Krajícek; P Pavel; P Firt
Journal:  World J Surg       Date:  1980-09       Impact factor: 3.352

3.  Induction of drug metabolizing enzymes by sulfinpyrazone.

Authors:  E Walter; C Staiger; J de Vries; R Zimmermann; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 4.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.